Skip to main content
logo
Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.1000
+0.0020 (2.04%)
Oct 16, 2026, 4:00 PM EST

Inhibitor Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
17810163756
Market Cap Growth
110.51%-25.02%-34.56%-57.47%-34.06%332.17%
Enterprise Value
175464261
Last Close Price
0.110.040.060.090.100.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----3.12-
PB Ratio
--6.015.223.004.49-15.59
P/TBV Ratio
--5.223.004.49-
P/OCF Ratio
----3.17-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.02-0.05--0.05-0.06
Net Debt / Equity Ratio
0.181.79-2.82-1.67-1.39-0.05
Quick Ratio
2.953.107.9013.2917.610.05
Current Ratio
3.363.198.0313.4517.640.09
Return on Equity (ROE)
--952.30%-91.88%-44.57%517.86%-
Return on Assets (ROA)
-92.70%-52.20%-31.22%-20.34%-6.83%-213.47%
Return on Capital Employed (ROCE)
-729.10%-196.40%-73.40%-41.10%-5.80%52.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-17.32%-42.50%-32.24%-19.12%32.53%-0.53%
Buyback Yield / Dilution
-0.22%-0.14%-0.18%53.04%2.67%-1.16%